NVLG: H1 2024 revenue up 11.5% to ₪1.64B; net income stable; ₪15M dividend declared

About this update from Novolog (pharm Up 1966) Ltd.

Revenue grew 11.5% year-over-year to ₪1.64B in H1 2024, with net income stable at ₪13.3M and Adjusted EBITDA up 3.7%. Dividend of ₪15M declared; no material impact from Israel's credit downgrade. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Novolog (pharm Up 1966) Ltd.